| Literature DB >> 34959945 |
Katarzyna Micielska1,2, Marta Flis3, Jakub Antoni Kortas4, Ewa Rodziewicz-Flis5, Jędrzej Antosiewicz6, Krystian Wochna7, Giovanni Lombardi8,9, Ewa Ziemann9.
Abstract
The COVID-19 pandemic and subsequent self-isolation exacerbated the problem of insufficient amounts of physical activity and its consequences. At the same time, this revealed the advantage of vitamin D. Thus, there was a need to verify the effects of those forms of training that can be performed independently. In this study, we examined the effects of Nordic walking (NW) and high intensity interval training (HIIT) with regard to the impact of the metabolite vitamin D. We assigned 32 overweight adults (age = 61 ± 12 years) to one of two training groups: NW = 18 and HIIT = 14. Body composition assessment and blood sample collection were conducted before starting the training programs and a day after their completion. NW training induced a significant decrease in myostatin (p = 0.05) concentration; however, the range was dependent on the baseline concentrations of vitamin D metabolites. This drop was accompanied by a significant negative correlation with the decorin concentration. Unexpectedly, NW caused a decrement in both forms of osteocalcin: undercarboxylated (Glu-OC) and carboxylated-type (Gla-OC). The scope of Glu-OC changes was dependent on a baseline concentration of 25(OH)D2 (r = -0.60, p = 0.01). In contrast, the HIIT protocol did not induce any changes. Overall results revealed that NW diminished the myostatin concentration and that this effect is more pronounced among adults with a sufficient concentration of vitamin D metabolites.Entities:
Keywords: 24,25(OH)2D3; 25(OH)D3; 3-epi-25(OH)D3; aging; decorin; myokines; osteokines
Mesh:
Substances:
Year: 2021 PMID: 34959945 PMCID: PMC8705296 DOI: 10.3390/nu13124393
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Characteristic of participants.
| NW ( | HIIT ( | rANOVA | |||
|---|---|---|---|---|---|
| I | II | I | II | Group × Time | |
|
| |||||
| BF/FFM [kg⋅kg−1] | 0.47 + 0.17 | 0.47 + 0.16 | 0.51 ± 0.18 | 0.50 ± 0.19 | 0.28 |
| BM/FFM [kg⋅kg−1] | 1.47 + 0.17 | 1.47 + 0.16 | 1.51 ± 0.18 | 1.50 ± 0.19 | 0.28 |
Data are presented as mean ± SD; rANOVA- analysis of variance with repeated measure; NW—Nordic walking group, HIIT—high intensity interval training group, I—before the intervention, II—24 h after completing training procedures; BF—body fat, FFM—free fat mass, BM—body mass.
Glucose, lipids and metabolite of vitamin D parameters before and after NW and HIIT trainings programs.
| NW ( | HIIT ( | rANOVA | |||
|---|---|---|---|---|---|
| I | II | I | II | Group × Time | |
| Glucose homeostasis indicators | |||||
| Glucose [mg⋅dL−1] | 100.83 ± 21.92 | 93.69 ± 6.01 | 100.36 ± 8.70 | 96.29 ± 8.88 | 0.73 |
| Insulin [µIU⋅mL−1] | 7.80 ± 4.87 | 8.19 ± 4.15 | 7.92 ± 4.90 | 8.19 ± 6.02 | 0.62 |
| QUICKI | 0.359 ± 0.04 | 0.357 ± 0.03 | 0.358 ± 0.04 | 0.362 ± 0.04 | 0.42 |
| HOMA-IR | 2.02 ± 1.51 | 1.88 ± 1.10 | 2.02 ± 1.38 | 2.01 ± 1.64 | 0.48 |
| Lipid profile | |||||
| Total cholesterol [mg⋅dL−1] | 232.50 ± 35.05 | 231.06 ± 35.68 | 178.93 ± 43.71 | 176.86 ± 31.34 | 0.94 |
| HDL cholesterol [mg⋅dL−1] | 77.75 ± 29.39 | 73.75 ± 20.43 | 54.45 ± 15.52 | 54.79 ± 15.27 | 0.27 |
| LDL cholesterol [mg⋅dL−1] | 133.44 ± 37.36 | 133.5 ± 41.35 | 104.94 ± 35.48 | 101.71 ± 28.21 | 0.63 |
| Triglycerides [mg⋅dL−1] | 105.63 ± 35.34 | 118.75 ± 39.74 | 97.07 ± 61.73 | 101.43 ± 44.04 | 0.54 |
| Vitamin D metabolites | |||||
| 25(OH)D3 [ng⋅mL−1] | 27.61 ± 10.82 | 27.78 ± 7.86 | 23.8 ± 5.18 | 25.54 ± 7.06 | 0.21 |
| 25(OH)D2 [ng⋅mL−1] | 0.52 ± 0.15 | 0.47 ± 0.11 | 0.44 ± 0.16 | 0.45 ± 0.15 | 0.08 |
| 24,25(OH)2D3 [ng⋅mL−1] | 2.62 ± 1.59 | 2.68 ± 1.43 | 2.12 ± 0.71 | 2.16 ± 0.83 | 0.94 |
| 3-epi-25(OH)D3 [ng⋅mL−1] | 1.34 ± 0.59 | 1.61 ± 0.68 | 1.23 ± 0.41 | 1.37 ± 0.63 | 0.27 |
Data are presented as mean ± SD; rANOVA—analysis of variance with repeated measure; I—before the intervention, II—24 h after completing training procedures; QUICKI—quantitative insulin sensitivity check index; HOMA-IR—homoeostasis model assessment of insulin resistance; HDL cholesterol—high density lipoprotein cholesterol; LDL cholesterol—low density lipoprotein cholesterol, 25(OH)D3-25-hydroxyvitamin D3, 25(OH)D2—25-hydroxyvitamin D2, 24,25(OH)2D3—24,25-dihydroxyvitamin D3, 3-epi-25(OH)D3—3 epimer of 25-hydroxyvitamin D3.
Figure 1Myokines (A,B) and osteokines (C,D) concentration changes in response to applied training protocols: Nordic walking (NW; n = 18) and high intensity interval training (HIIT; n = 14). Data are presented as mean ± SD; * statistically significant result (post hoc tests); Glu-OC—undercarboxylated osteocalcin; Gla-OC—carboxylated-type of osteocalcin.
Figure 2Myostatin concentration delta changes (∆ POST to PRE) dependant on baseline level of metabolite vitamin D in NW training group: (A) baseline 25(OH)D3, (B) baseline 24,25(OH)2D3 and (C) baseline 3-epi-25(OH)D3; * statistically significant result (post hoc tests)—p < 0.05.
Figure 3Correlation of myostatin and decorin concentration delta changes (∆ POST to PRE) in response to NW training.
Figure 4Correlation between baseline concentration of 25(OH)D2 and delta changes (∆ POST to PRE) in undercarboxylated osteocalcin (Glu-OC) among participants from NW group.
Figure 5The differences between NW (n = 18) and HIIT (n = 14) training programs expressed as delta changes (∆ POST to PRE) in myokines (A,B,E) and osteokines (C,D) concentration, before and after applied interventions. Values are statistically significant. Analysis of variance (rANOVA) was used.